FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicola Tinari

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Rossano Lattanzio; Marco Marchisio; Elisa Melucci; Sebastiano Miscia; Marcella Mottolese; Pier Giorgio Natali; Letizia Perracchio; Mauro Piantelli; Nicola Tinari; Saverio Alberti; Anna Di Benedetto; Cristiana Ercolani; Marco Falasca; Stefano Iacobelli; Rossana La Sorda
Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy.
Domenico Angelucci; Giampiero Ausili-Cefaro; Graziella Castrilli; Ettore Cianchetti; Pasquale Cioffi; Michele De Tursi; Antonino Grassadonia; Simona Grossi; Stefano Iacobelli; Laura Iezzi; Paolo Noccioli; Maria Teresa Scognamiglio; Nicola Tinari; Lucia Anna Ursini; Marinella Zilli; Clara Natoli
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice.
Reza Ghasemi; Antonino Grassadonia; Clara Natoli; Enza Piccolo; Nicola Tinari; Federica Tomao; Stefano Iacobelli
Tumor-derived microvesicles: the metastasomes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicola Tinari (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rossano Lattanzio; Marco Marchisio; Elisa Melucci; Sebastiano Miscia; Marcella Mottolese; Pier Giorgio Natali; Letizia Perracchio; Mauro Piantelli; Nicola Tinari; Saverio Alberti; Anna Di Benedetto; Cristiana Ercolani; Marco Falasca; Stefano Iacobelli; Rossana La Sorda
Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy.
International journal of cancer. Journal international du cancer 2013;132(5):1022-31.
2013: Domenico Angelucci; Giampiero Ausili-Cefaro; Graziella Castrilli; Ettore Cianchetti; Pasquale Cioffi; Michele De Tursi; Antonino Grassadonia; Simona Grossi; Stefano Iacobelli; Laura Iezzi; Paolo Noccioli; Maria Teresa Scognamiglio; Nicola Tinari; Lucia Anna Ursini; Marinella Zilli; Clara Natoli
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice.
Journal of cancer research and clinical oncology 2013;139(2):269-80.
2013: Reza Ghasemi; Antonino Grassadonia; Clara Natoli; Enza Piccolo; Nicola Tinari; Federica Tomao; Stefano Iacobelli
Tumor-derived microvesicles: the metastasomes.
Medical hypotheses 2013;80(1):75-82.
2013: Enza Piccolo; Daniela Semeraro; Francesca Spinella; Pavlos Stampolidis; Nicola Tinari; Sara Traini; Axel Ullrich; Anna Bagnato; Albana Cumashi; Maurizia D'Egidio; Annalisa Di Risio; Imma Fichera; Rossana La Sorda; Rossano Lattanzio; Clara Natoli; Mauro Piantelli; Stefano Iacobelli
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis.
Journal of molecular medicine (Berlin, Germany) 2013;91(1):83-94.
2012: Corrado Ficorella; Clara Natoli; Giampiero Porzio; Paola Lanfiuti Baldi; Gemma Bruera; Katia Cannita; Nicola Tinari; Enrico Ricevuto
Triplet chemotherapy in patients with metastatic colorectal cancer: toward the best way to safely administer a highly active regimen in clinical practice.
Clinical colorectal cancer 2012;11(4):229-37.
2012: Nicola Tinari; Marinella Zilli; Liborio Stuppia; Michele De Tursi; Antonino Grassadonia; Stefano Iacobelli; Clara Natoli
An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors.
Current cancer drug targets 2012;12(4):439-52.
2012: G Sala; Nicola Tinari; S Traini; Giovina Vianale; Maurizia D'Egidio; Stefano Iacobelli; Rossano Lattanzio; Raffaella Muraro; P G Natali; Mauro Piantelli; Enza Piccolo; C Rossi
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling.
Oncogene 2012;31(10):1275-86.
2011: Clara Natoli; S Palmeri; V Ramazzotti; M Salvatore; Nicola Tinari; M Zilli; P Giacomini; M Landriscina; O Nappi; P G Natali; Stefano Iacobelli
Unknown primary tumors.
Biochimica et biophysica acta 2011;1816(1):13-24.
2011: Diego O Croci; Albana Cumashi; Natalia A Ushakova; Marina E Preobrazhenskaya; Antonio Piccoli; Licia Totani; Nadezhda E Ustyuzhanina; Maria I Bilan; Anatolii I Usov; Alexey A Grachev; Galina E Morozevich; Albert E Berman; Craig J Sanderson; Maeve Kelly; Patrizia Di Gregorio; Cosmo Rossi; Nicola Tinari; Stefano Iacobelli; Gabriel A Rabinovich; Nikolay E Nifantiev
Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from Laminaria saccharina brown seaweed.
PloS one 2011;6(2):e17283.
2009: Marinella Zilli; Antonino Grassadonia; Nicola Tinari; Alessia Di Giacobbe; Simona Gildetti; Jamara Giampietro; Clara Natoli; Stefano Iacobelli
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer.
Biochimica et biophysica acta 2009;1795(1):62-81.
2008: Albana Cumashi; Nicola Tinari; Cosmo Rossi; Rossano Lattanzio; Clara Natoli; Mauro Piantelli; Stefano Iacobelli
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts.
Cancer letters 2008;270(2):229-33.
2008: Anna Iolanda Rispoli; Maria Francesca Morelli; Enrico Ricevuto; Katia Cannita; Alessandra Santomaggio; Maria Mancini; Marianna Tudini; G Cianci; Giampiero Porzio; Paola Lanfiuti Baldi; Christiana Zorica Di Rocco; Nicola Tinari; Stefano Iacobelli; Paolo Marchetti; Corrado Ficorella
Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancer.
The breast journal 2008;14(1):116-7.
2007: Antonino Grassadonia; Nicola Tinari; Bruno Fiorentino; Minoru Nakazato; Hyun-Kyung Chung; Cesidio Giuliani; Giorgio Napolitano; Stefano Iacobelli; T Kevin Howcroft; dinah singer; Leonard D Kohn
Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein.
Endocrinology 2007;148(7):3507-17.
2007: Ida Iurisci; tyvin rich; Francis Lévi; Pasquale F Innominato; Nicola Tinari; Luciana Irtelli; Michele De Tursi; Antonino Grassadonia; Stefano Iacobelli
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):e17-9.
2007: Clara Natoli; Ettore Cianchetti; Nicola Tinari; Domenico Angelucci; Antonino Grassadonia; M Zilli; Corrado Ficorella; Enrico Ricevuto; S Grossi; Michele De Tursi; C Carella; Anna Iolanda Rispoli; Stefano Iacobelli
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(6):1015-20.
2007: Albana Cumashi; Natalia A Ushakova; Marina E Preobrazhenskaya; Armida D'Incecco; Antonio Piccoli; Licia Totani; Nicola Tinari; Galina E Morozevich; Albert E Berman; Maria I Bilan; Anatolii I Usov; Nadezhda E Ustyuzhanina; Alexey A Grachev; Craig J Sanderson; Maeve Kelly; Gabriel A Rabinovich; Stefano Iacobelli; Nikolay E Nifantiev
A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds.
Glycobiology 2007;17(5):541-52.
2006: Corrado Ficorella; Enrico Ricevuto; Maria Francesca Morelli; R Morese; Katia Cannita; G Cianci; Giampiero Porzio; Zorika Christiana Di Rocco; Federica De Galitiis; Michele De Tursi; Nicola Tinari; Stefano Iacobelli; Piero Marchetti
Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding study.
Oncology reports 2006;15(5):1345-50.
2006: Nicola Tinari; Rossano Lattanzio; Clara Natoli; Ettore Cianchetti; Domenico Angelucci; Enrico Ricevuto; Corrado Ficorella; Paolo Marchetti; Saverio Alberti; Mauro Piantelli; Stefano Iacobelli
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(5):1501-6.
2006: Gabriel A Rabinovich; Albana Cumashi; German Ariel Bianco; Domenico Ciavardelli; Ida Iurisci; Maurizia D'Egidio; Enza Piccolo; Nicola Tinari; Nikolay E Nifantiev; Stefano Iacobelli
Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis.
Glycobiology 2006;16(3):210-20.
2005: Anna Maria Valentini; Palma A Iacovazzi; Mario Correale; Michele Pirrelli; Raffaele Armentano; S Iacobelli; Nicola Tinari; Ida Iurisci; Maria Lucia Caruso
Immunohistochemical and serological 90K/Mac-2BP detection in hepatocellular carcinoma patients: different behaviour of two monoclonal antibodies.
Medicinal chemistry (Shāriqah (United Arab Emirates)) 2005;1(2):185-9.
2004: Omer Kalayci; Esra Birben; Nicola Tinari; Tsuyoshi Oguma; Stefano Iacobelli; Craig M Lilly
Role of 90K protein in asthma and TH2-type cytokine expression.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2004;93(5):485-92.
2004: Antonino Grassadonia; Nicola Tinari; Bruno Fiorentino; Koichi Suzuki; Minoru Nakazato; Michele De Tursi; Cesidio Giuliani; Giorgio Napolitano; dinah singer; Stefano Iacobelli; Leonard D Kohn
The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides.
Endocrinology 2004;145(10):4728-36.
2004: Corrado Ficorella; Maria Francesca Morelli; Enrico Ricevuto; Katia Cannita; Giampiero Porzio; P Lanfiuti Baldi; G Cianci; Zorika Christiana Di Rocco; Clara Natoli; Nicola Tinari; Federica De Galitiis; F Calista; Piero Marchetti
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study.
British journal of cancer 2004;91(4):618-20.
2004: Maria Dorrucci; Stefano Iacobelli; barbara suligoi; P Pezzotti; Alessandro Sinicco; G Angarano; Nicola Tinari; G Rezza
Longitudinal analysis of the 90K glycoprotein in the Italian HIV-seroconversion study: temporal trend and predictability of the maturity of HIV infection.
Journal of biological regulators and homeostatic agents 2004;18(1):18-25.
2004: Antonino Grassadonia; Nicola Tinari; Ida Iurisci; Enza Piccolo; Albana Cumashi; Pasquale F Innominato; Maurizia D'Egidio; Clara Natoli; Mauro Piantelli; Stefano Iacobelli
90K (Mac-2 BP) and galectins in tumor progression and metastasis.
Glycoconjugate journal 2004;19(7-9):551-6.
2002: Mauro Piantelli; Stefano Iacobelli; Giovanni Almadori; Manuela Iezzi; Nicola Tinari; Clara Natoli; Gabriella Cadoni; Libero Lauriola; Franco O Ranelletti
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(18):3850-6.
2002: Anna Maria Cesinaro; Clara Natoli; Antonino Grassadonia; Nicola Tinari; Stefano Iacobelli; Gian Paolo Trentini
Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions.
The Journal of investigative dermatology 2002;119(1):187-90.
2002: Gabriel A Rabinovich; Linda G Baum; Nicola Tinari; Roberto Paganelli; Clara Natoli; Fu-Tong Liu; Stefano Iacobelli
Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?
Trends in immunology 2002;23(6):313-20.
2002: Antonio Marchetti; Nicola Tinari; Fiamma Buttitta; Antonio Chella; Carlo Alberto Angeletti; Rocco Sacco; Felice Mucilli; Axel Ullrich; Stefano Iacobelli
Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients.
Cancer research 2002;62(9):2535-9.
2001: Nicola Tinari; I Kuwabara; M E Huflejt; P F Shen; Stefano Iacobelli; Fu-Tong Liu
Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation.
International journal of cancer. Journal international du cancer 2001;91(2):167-72.
2000: B Fornarini; C D'Ambrosio; Clara Natoli; Nicola Tinari; V Silingardi; Stefano Iacobelli
Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo.
Blood 2000;96(9):3282-5.
2000: Paola Matarrese; Nicola Tinari; M L Semeraro; Clara Natoli; Stefano Iacobelli; Walter Malorni
Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis.
FEBS letters 2000;473(3):311-5.
2000: Ida Iurisci; Nicola Tinari; Clara Natoli; Domenico Angelucci; Ettore Cianchetti; Stefano Iacobelli
Concentrations of galectin-3 in the sera of normal controls and cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1389-93.
2000: Clara Natoli; M T Scognamiglio; M T Martino; Luciana Irtelli; Michele De Tursi; Ettore Cianchetti; E Mascitelli; Nicola Tinari; Stefano Iacobelli
Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer.
Anticancer research 2000;20(2B):1253-6.
2000: Paola Matarrese; O Fusco; Nicola Tinari; Clara Natoli; Fu-Tong Liu; M L Semeraro; Walter Malorni; Stefano Iacobelli
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties.
International journal of cancer. Journal international du cancer 2000;85(4):545-54.
1999: B Fornarini; Stefano Iacobelli; Nicola Tinari; Clara Natoli; Maurizio de Martino; G Sabatino
Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections.
Clinical and experimental immunology 1999;115(1):91-4.
1998: Stefano Iacobelli; Luciana Irtelli; Rocco Sacco; M Martino; E Mascitelli; L Basilico; M Scognamiglio; Clara Natoli; O Fusco; Nicola Tinari; V Beltrami
A phase II study of neoadjuvant chemotherapy with cisplatin epirubicin and VP-16 for stage III unresectable non-small cell lung cancer.
Anticancer research 1998;18(3B):2081-4.
1998: Nicola Tinari; Clara Natoli; N D'Ostilio; Florio Ghinelli; Laura Sighinolfi; L Ortona; Enrica Tamburrini; M Piazza; Antonio Chirianni; L Guerra; P Di Gregorio; Stefano Iacobelli
90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/L.
Archives of pathology & laboratory medicine 1998;122(2):178-81.
1997: Nicola Tinari; Maurizia D'Egidio; Stefano Iacobelli; M Bowen; Gary C Starling; Carrie Seachord; Richard P Darveau; A Aruffo
Identification of the tumor antigen 90K domains recognized by monoclonal antibodies SP2 and L3 and preparation and characterization of novel anti-90K monoclonal antibodies.
Biochemical and biophysical research communications 1997;232(2):367-72.
1996: Renzo Ranaldi; Alfredo Santinelli; G Fabris; B Mannello; C Natoli; Nicola Tinari; Italo Bearzi
A flow cytometric study of early gastric cancer. The detection of high proliferative activity adds important information to the prognosis.
Pathology, research and practice 1996;192(12):1202-5.
1996: Marco Artini; C Natoli; Nicola Tinari; Antonio Costanzo; R Marinelli; Clara Balsano; P Porcari; D Angelucci; M D'Egidio; Massimo Levrero; S Iacobelli
Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients.
Journal of hepatology 1996;25(2):212-7.
1996: N D'Ostilio; Clara Natoli; A Grassadonia; N Rossi; P Di Stefano; C Amatetti; Nicola Tinari; Stefano Iacobelli
Prognostic value of a novel interferon-inducible 90K tumor antigen.
Annals of the New York Academy of Sciences 1996;784():288-93.
1995: Stefano Iacobelli; A Ullrich; Nicola Tinari; L Ortona; E Tamburrini; M D'Egidio; Florio Ghinelli; Laura Sighinolfi; M Piazza; A Chirianni
The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10(4):450-6.
1995: Nicola Gentiloni; P Caradonna; Guido Costamagna; N D'Ostilio; Vincenzo Perri; Massimiliano Mutignani; S Febbraro; Nicola Tinari; S Iacobelli; C Natoli
Pancreatic juice 90K and serum CA 19-9 combined determination can discriminate between pancreatic cancer and chronic pancreatitis.
The American journal of gastroenterology 1995;90(7):1069-72.
1995: Stefano Iacobelli; C Garufi; Luciana Irtelli; M T Martino; F Santobuono; G Vicario; Nicola Tinari; Bruno Fiorentino; P Innocenti; Clara Natoli
A phase I study of recombinant interferon-alpha administered as a seven-day continuous venous infusion at circadian-rhythm modulated rate in patients with cancer.
American journal of clinical oncology 1995;18(1):27-31.
1994: Clara Natoli; L Ortona; E Tamburrini; Nicola Tinari; P Di Stefano; M D'Egidio; Florio Ghinelli; Laura Sighinolfi; N D'Ostilio; M Piazza
Elevated serum levels of a 90,000 daltons tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV).
Anticancer research 1994;14(3B):1457-60.
1994: Stefano Iacobelli; Piero Sismondi; Maurizia Giai; M D'Egidio; Nicola Tinari; C Amatetti; P Di Stefano; Clara Natoli
Prognostic value of a novel circulating serum 90K antigen in breast cancer.
British journal of cancer 1994;69(1):172-6.
1993: G Longo; Clara Natoli; D Rafanelli; Nicola Tinari; M Morfini; P Rossi-Ferrini; N D'Ostilio; Stefano Iacobelli
Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients.
British journal of haematology 1993;85(1):207-9.
1993: Nathaniel C Briggs; C Natoli; Nicola Tinari; M D'Egidio; James J Goedert; Stefano Iacobelli
A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men.
AIDS research and human retroviruses 1993;9(9):811-6.
1993: Stefano Iacobelli; Ines Bucci; M D'Egidio; Cesidio Giuliani; Clara Natoli; Nicola Tinari; M Rubistein; J Schlessinger
Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines.
FEBS letters 1993;319(1-2):59-65.
1993: Clara Natoli; C Garufi; Nicola Tinari; M D'Egidio; G Lesti; L A Gaspari; R Visini; Stefano Iacobelli
Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease.
British journal of cancer 1993;67(3):564-7.
1993: Nicola Tinari; Clara Natoli; D Angelucci; Raffaele Tenaglia; Bruno Fiorentino; P Di Stefano; C Amatetti; A Zezza; M Nicolai; Stefano Iacobelli
DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications.
Cancer 1993;71(4):1289-96.
1992: Bruno Fiorentino; P Di Stefano; Cesidio Giuliani; C Amatetti; Nicola Tinari; Clara Natoli; C Garufi; Stefano Iacobelli
Immunological effects of alternative weekly interferon-alpha-2b and low dose interleukin-2 in patients with cancer.
British journal of cancer 1992;66(5):981-3.
1992: R Visini; L Aceto; G Masi; C Rapani; G Sica; R Trulli; M Zakaria; Achille Lucio Gaspari; Nicola Tinari; Clara Natoli
[Totally implantable systems for long-term chemotherapeutic treatment].
Recenti progressi in medicina 1992;83(10):564-6.
1992: Clara Natoli; Bruno Fiorentino; P Di Stefano; C Amatetti; Nicola Tinari; Stefano Iacobelli
Combinations of biological response modifiers: rationale and clinical responses.
Pharmacological research : the official journal of the Italian Pharmacological Society 1992;26 Suppl 2():102-3.
1992: P Di Stefano; C Natoli; S Iacobelli; Nicola Tinari; Bruno Fiorentino; C Amatetti; L Artese; G Pizzicannella
DNA ploidy and S-phase fraction in pulmonary carcinoids.
European journal of cancer (Oxford, England : 1990) 1992;28A(11):1933-4.